@RaceOncology reading these comments above about possible outcomes for bisantrene & RAC, do you or the board have a longer term vision for the company, ie post bisantrene being validated as CPAC, that you can articulate
For example, would you like to see
- bis being sold off completely
- bis being licenced providing substantional annuity income to fund other endeavours
- RAC becoming a molecule development company (noting the 39 unique FTO protein-binding molecules recently discovered)
- RAC being sold off lock, stock & barrel
- any combination of the above
- somehting else
Interested in your thoughts......
(20min delay)